| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |